Pentobarbital during pregnancy and lactation

 Pentobarbital during pregnancy and lactation, Pentobarbitalcategory by FDA, its use during pregnancy and lactation its teratogenic effects are described.

Small amount of drug excrete into breast milk, if required low dose should be prescribed.

Pentobarbital during pregnancy and lactation
Pregnancy	Category D       ( by FDA )
	Pentobarbital drug crosses the placenta animal controlled studies revealed congenital malformation – neural tube defects, cleft lips, cleft palates, cardiac defects, and microcephaly. Use with caution when benefit outweighs risk
Breast feeding	Pentobarbital excreted into breast milk, use with caution. No recommendations.